Search

everythinglearnresearchcommunity

for

Search:↓

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

A natural steroid in the body may protect against eye damage in glaucoma.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Suppressing certain hormones might help prevent prostate cancer.